2003
DOI: 10.1038/sj.eye.6700495
|View full text |Cite
|
Sign up to set email alerts
|

Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion

Abstract: Purpose Retinal artery occlusion is a common vision-threatening disease. Among other risk factors, coagulopathies leading to a hypercoagulable state have been associated with retinal artery occlusion. Numerous studies have shown that two genetic variants, factor V Leiden and prothrombin 20210A, cause a procoagulant state. However, their role in the pathogenesis of retinal artery occlusion is still unclear. The purpose of the present study was therefore to investigate a possible association between factor V Lei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0
3

Year Published

2007
2007
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 26 publications
0
14
0
3
Order By: Relevance
“…They include familial and acquired thrombophilia (low protein C, lupus anticoagulant) in patients with CRAO38, antiphospholipid antibodies39 and homocysteinemia38,40,41; however, factor V Leiden, prothrombin 20210A and homozygosity for the MTHFR C677T have not been found to be associated with RAO27,40. In our study we did not conduct hematological studies systematically; therefore, we have no information on this aspect of RAO.…”
Section: Discussionmentioning
confidence: 93%
“…They include familial and acquired thrombophilia (low protein C, lupus anticoagulant) in patients with CRAO38, antiphospholipid antibodies39 and homocysteinemia38,40,41; however, factor V Leiden, prothrombin 20210A and homozygosity for the MTHFR C677T have not been found to be associated with RAO27,40. In our study we did not conduct hematological studies systematically; therefore, we have no information on this aspect of RAO.…”
Section: Discussionmentioning
confidence: 93%
“…All the available studies [14][15][16][17][18][19][20][21][22][23][24][25][26][27], however, have assessed one or just few factors.…”
Section: Discussionmentioning
confidence: 99%
“…A systemic evaluation should therefore include the search for these conditions in each patient with RAO. In the literature only few data about the prevalence of thrombophilic conditions in RAO are available; generally they are case reports and studies on small series of patients in whom the authors examined the association of RAO with separate risk factors such as hyperhomocysteinaemia [14][15][16][17][18][19], C677T methylenetetrahydrofolate reductase MTHFR C677T polymorphism [15][16][17][18]20], factor V Leiden [16,[19][20][21][22][23][24], prothrombin G20210A polymorphism [16,[19][20][21][22][23][24], and lipoprotein(a) levels [25][26][27]. Primary antiphospholipid syndrome has been associated with severe retinal vascular occlusion in young patients [28].…”
Section: Introductionmentioning
confidence: 99%
“…Several forms of RAO exist [8][9][10], and the mechanism behind them is still not fully understood [6]. RAO is associated with systemic cardiovascular disease [3,4,18,19,27,[32][33][34], and one reason for this is hypoperfusion due to severe stenosis of the carotid artery, but only for stenosis > 70% [1,7,24,29]. It is assumed that systemic emboli, mainly from the carotid artery but also possibly from endocarditis, are the main reason for RAO [11].…”
Section: Introductionmentioning
confidence: 99%
“…Since the EAGLE study showed that intra-arterial thrombolysis is not beneficial for patients with RAO [28], current research has mainly focused on risk factors for RAO [1,3,4,11,18,19,21,23,27,[32][33][34]. Thus, understanding of flow conditions and blood clot dynamics in the internal carotid artery (ICA) and ophthalmic artery (OA) may help to improve treatment concepts for RAO.…”
Section: Introductionmentioning
confidence: 99%